Clinical, immunological and molecular findings of 8 patients with typical and atypical severe combined immunodeficiency: identification of 7 novel mutations by whole exome sequencing

[1]  L. Notarangelo,et al.  Outcomes Following Treatment for Adenosine Deaminase Deficient Severe Combined Immunodeficiency: A Report from the PIDTC. , 2022, Blood.

[2]  S. Barış,et al.  Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency , 2022, Journal of Clinical Immunology.

[3]  E. Perez.  Future of Therapy for Inborn Errors of Immunity , 2022, Clinical Reviews in Allergy & Immunology.

[4]  L. Opitz,et al.  Whole‐exome sequencing of T‐B+ severe combined immunodeficiency in Egyptian infants, JAK3 predominance and novel variants , 2020, Clinical and experimental immunology.

[5]  C. Cunningham-Rundles,et al.  Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry , 2020, Journal of Clinical Immunology.

[6]  S. McGrath-Morrow,et al.  DNA methylation and gene expression signatures are associated with ataxia-telangiectasia phenotype , 2020, Scientific Reports.

[7]  Jinqiao Sun,et al.  LIG4 syndrome: clinical and molecular characterization in a Chinese cohort , 2020, Orphanet Journal of Rare Diseases.

[8]  J. Casanova,et al.  Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification , 2020, Journal of Clinical Immunology.

[9]  E. Secord,et al.  Newborn Screening for Severe Combined Immunodeficiency. , 2019, Pediatric clinics of North America.

[10]  Ji Chen,et al.  Disseminated Bacille Calmette‐Guérin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation , 2019, Pediatric dermatology.

[11]  G. Giardino,et al.  Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network , 2019, Front. Immunol..

[12]  J. Barata,et al.  Flip the coin: IL-7 and IL-7R in health and disease , 2019, Nature Immunology.

[13]  L. Hammarström,et al.  IL2RG hypomorphic mutation: identification of a novel pathogenic mutation in exon 8 and a review of the literature , 2019, Allergy, Asthma & Clinical Immunology.

[14]  L. Notarangelo,et al.  The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). , 2019, The Journal of allergy and clinical immunology.

[15]  J. Walter,et al.  Partial RAG deficiency in a patient with varicella infection, autoimmune cytopenia, and anticytokine antibodies. , 2018, The journal of allergy and clinical immunology. In practice.

[16]  Alexandros Kouris,et al.  VarSome: the human genomic variant search engine , 2018, bioRxiv.

[17]  A. Kolios,et al.  Late presenting atypical severe combined immunodeficiency (SCID) associated with a novel missense mutation in DCLRE1C , 2018, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[18]  Michael Seleman,et al.  A novel mutation in the JH4 domain of JAK3 causing severe combined immunodeficiency complicated by vertebral osteomyelitis. , 2017, Clinical immunology.

[19]  C. Bacchelli,et al.  Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency , 2017, The Journal of allergy and clinical immunology.

[20]  A. Gennery,et al.  DNA ligase IV syndrome; a review , 2016, Orphanet Journal of Rare Diseases.

[21]  M. Sigvardsson,et al.  Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT , 2016, The Journal of experimental medicine.

[22]  L. Notarangelo,et al.  Ligase-4 Deficiency Causes Distinctive Immune Abnormalities in Asymptomatic Individuals , 2016, Journal of Clinical Immunology.

[23]  Y. Barak,et al.  Deep intronic mis-splicing mutation in JAK3 gene underlies T-B+NK- severe combined immunodeficiency phenotype. , 2016, Clinical immunology.

[24]  A. Schäffer,et al.  DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency. , 2015, Human molecular genetics.

[25]  A. Fischer,et al.  Severe combined immunodeficiencies and related disorders , 2015, Nature Reviews Disease Primers.

[26]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[27]  L. Notarangelo,et al.  Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. , 2014, The Journal of allergy and clinical immunology.

[28]  J. Verbsky,et al.  Newborn Screening for Severe Combined Immunodeficiency , 2013 .

[29]  L. Notarangelo,et al.  Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment. , 2013, The Journal of allergy and clinical immunology.

[30]  K. Schwarz,et al.  Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. , 2011, Clinical immunology.

[31]  R. Abraham,et al.  Functional analysis of LAT in TCR-mediated signaling pathways using a LAT-deficient Jurkat cell line. , 1999, International immunology.

[32]  Eric O Long,et al.  Essential role of LAT in T cell development. , 1999, Immunity.

[33]  S. Ozen,et al.  A Novel Missense LIG4 Mutation in a Patient With a Phenotype Mimicking Behçet’s Disease , 2018, Journal of Clinical Immunology.

[34]  M. Eslamian,et al.  Clinical, Laboratory, and Molecular Findings for 63 Patients With Severe Combined Immunodeficiency: A Decade´s Experience. , 2017, Journal of investigational allergology & clinical immunology.

[35]  E. Brooks,et al.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. , 2001, Blood.